PG Gobbi, ML Ghirardelli, P Avanzini, L Baldini, G Quarta, C Stelitano, C Broglia, C Loni, V Silingardi, E Ascari. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin’s lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL). haematol [Internet]. 2000Mar.1 [cited 2024Nov.26];85(3):263-8. Available from: https://haematologica.org/article/view/1617